Novartis has teamed up with the NFL in a multi-year partnership, marking the first such collaboration between the football ...

The NFL have signed its first-ever pharmaceutical partner in a multi-year deal with Novartis to focus on the NFL’s health ...

Novartis, a leading innovative medicines company, and the National Football League (NFL) announced an unprecedented partnership that names Novartis as the official first-in-category corporate ...

The National Football League has signed its first-ever pharmaceutical partner in a multi-year deal with Switzerland-based ...

The Maryland Senate voted to allow a state board to extend its mandate for lowering prescription drug costs to all residents.

Legend Biotech is building a new $150 million manufacturing plant, with its partner Johnson & Johnson, with the goal of ...

Today, Folia Health and Novartis Pharmaceuticals, Inc. proudly announce their collaboration on an innovative, at-home ...

The NFL has inked a multi-year deal with pharmaceutical giant Novartis, marking its first such partnership. This ...

The RNA inhibitor reduces levels of oxidized phospholipids, which are presumed to promote atherosclerosis, by more than 93%.

Multiple Sclerosis Therapeutics Size Multiple Sclerosis Therapeutics Market is estimated to be valued at USD 31.39 Bn in 2025 and is expect ...

Companies in the US, including Novo Nordisk, Boeing and Shein, are forming task forces to address the impact of Donald ...

North America Vision Care market is estimated to be valued at US$ 6.44 Bn in 2023 and is expected to exhibit a CAGR of 4.5% during the forecast period 2023-2030 Mr. Shah Coherent Market Insights Pvt.